Science Explorer Interactive view Map
Company · Cranbury · United States

Amicus Therapeutics (United States)

amicusrx.comROR OpenAlex
Research works
110
▼ 21% vs 2013–17
Citations
1.8k
16.7 per fractional work
Top-10% rate
13.8%
record average 16.5%
Open access
29%
world 28%

Not ranked overall: Amicus Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.09× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.35× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 7.21× its world share, 1 worksImmunology and Micro…Neuroscience: 0.36× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.35× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.34× its world share, 1 worksChemistryEngineering: 0.12× its world share, 0 worksEngineeringEnvironmental Science: 0.53× its world share, 0 worksEnvironmental ScienceMedicine: 2.93× its world share, 11 worksMedicineBusiness, Management and Accounting: 0.14× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 2.45× its world share, 1 worksEconomics, Econometr…Psychology: 0.05× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.3×. Every wedge is a field page.

Who are the top researchers at Amicus Therapeutics (United States)?

Ranked on the composite score, David J. Lockhart, Pol Boudes and Kenneth J. Valenzano lead among researchers whose main affiliation is Amicus Therapeutics (United States).

  1. 1 David J. Lockhart United States · #79,918 worldwide 394 citations · 26 works
  2. 2 Pol Boudes United States · #493,252 worldwide 42 citations · 24 works
  3. 3 Kenneth J. Valenzano United States · #659,327 worldwide 68 citations · 16 works
  4. 4 Xiaoyang Wu United States · #1,003,270 worldwide 30 citations · 18 works
  5. 5 Jay Barth United States · #1,219,195 worldwide 14 citations · 33 works
All ranked researchers at Amicus Therapeutics (United States)

Which keywords describe research at Amicus Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Parkinson's Disease, Enzyme Replacement Therapy, Lysosomal Storage Disorders, Metabolism, Neurodegeneration, Genetic Mutations, Epilepsy and Glycogen.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Parkinson's Disease28▲ 112×4 topics
  2. Enzyme Replacement Therapy27▲ 921×1 topic
  3. Lysosomal Storage Disorders27▲ 1274×1 topic
  4. Metabolism12▲ 16×5 topics
  5. Neurodegeneration11▲ 33×4 topics
  6. Genetic Mutations11▲ 19×5 topics
  7. Epilepsy11▲ 76×2 topics
  8. Glycogen10▲ 626×1 topic
  9. Myoclonic Disorders10▲ 626×1 topic
  10. Epidemiology7▲ 1.54×16 topics
  11. Cancer6▲ 3.6×11 topics
  12. Enzyme Regulation5▲ 94×2 topics
  13. Nucleotide Metabolism5▲ 130×1 topic
  14. Purine Biosynthesis5▲ 130×1 topic
  15. Drug Resistance5▲ 14×3 topics
  16. Chemotherapy5▲ 5.9×4 topics
  17. Endocytosis5▲ 90×1 topic
  18. Membrane Fusion5▲ 119×1 topic
  19. Glycosidase Inhibitors4▲ 80×1 topic
  20. Oligosaccharide Synthesis4▲ 80×1 topic
  21. Vector Control4▲ 35×2 topics
  22. Chagas Disease4▲ 147×1 topic
  23. Trypanosoma cruzi4▲ 147×1 topic
  24. Glycosylation4▲ 15×3 topics
  25. Glycans3▲ 34×1 topic
  26. Immune System3▲ 8.6×1 topic
  27. Mitochondrial Dysfunction3▲ 6.7×6 topics
  28. Neuropathic Pain2▲ 20×2 topics
  29. Primary Care2▲ 3.9×3 topics
  30. Tumor Targeting2▲ 12×2 topics
  31. Biotechnological Applications2▲ 33×1 topic
  32. Microbial Enzymes2▲ 33×1 topic
  33. Immunosuppressive Therapy2▲ 7.0×4 topics
  34. Metabolic Disorders1▲ 6.9×2 topics
  35. Autism Spectrum Disorders1▲ 14×2 topics
  36. Cysteamine Therapy1▲ 95×1 topic
  37. Cystinosis1▲ 95×1 topic
  38. Nanocarriers1▲ 28×1 topic
  39. Surface Engineering1▲ 11×1 topic
  40. Continuity of Care1▲ 18×1 topic

Which research topics does Amicus Therapeutics (United States) publish most on?

By volume in 2022–2025: Lysosomal Storage Disorders Research, Glycogen Storage Diseases and Myoclonus, Trypanosoma species research and implications and Immunotherapy and Immune Responses.

Lysosomal Storage Disord…5Lysosomal Storage Disorders Research: 5 fractional worksGlycogen Storage Diseases and Myoclonus: 2 fractional worksTrypanosoma species research and implications: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksWater Treatment and Disinfection: 0 fractional worksChemical Reactions and Isotopes: 0 fractional worksPotassium and Related Disorders: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksMetabolism and Genetic Disorders: 0 fractional works
PhysiologyRheumatologyEpidemiologyImmunology6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lysosomal Storage Disorders Research Physiology 5 works
  2. 2 Glycogen Storage Diseases and Myoclonus Rheumatology 2 works
  3. 3 Trypanosoma species research and implications Epidemiology 1 works
  4. 4 Immunotherapy and Immune Responses Immunology 1 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  6. 6 Water Treatment and Disinfection Health, Toxicology and Mutagenesis 0 works
  7. 7 Chemical Reactions and Isotopes Pharmaceutical Science 0 works
  8. 8 Potassium and Related Disorders Pulmonary and Respiratory Medicine 0 works
  9. 9 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  10. 10 Metabolism and Genetic Disorders Clinical Biochemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.7%not open71.3%

World: 28% of research is openly available.

with international co-authors27.8%domestic only72.2%

World: 19% is written across borders.

How has Amicus Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 21% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cranbury

All research institutions in Cranbury

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.